BioEclipse Therapeutics Company
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
.jpeg)
Technology:
Cell-based gene therapy
Industry:
Private
Headquarters:
San Francisco, California, United States
Founded Date:
2006-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
15699689
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-26
Last Funding Type:
Grant
Register and Claim Ownership